248 related articles for article (PubMed ID: 25162310)
1. Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium.
Bashir MR; Castelli P; Davenport MS; Larson D; Marin D; Hussain HK; Jaffe TA
Radiology; 2015 Jan; 274(1):141-8. PubMed ID: 25162310
[TBL] [Abstract][Full Text] [Related]
2. Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition.
Pietryga JA; Burke LM; Marin D; Jaffe TA; Bashir MR
Radiology; 2014 May; 271(2):426-34. PubMed ID: 24475864
[TBL] [Abstract][Full Text] [Related]
3. Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine.
Davenport MS; Caoili EM; Kaza RK; Hussain HK
Radiology; 2014 Jul; 272(1):123-31. PubMed ID: 24617733
[TBL] [Abstract][Full Text] [Related]
4. Transient Severe Motion Artifact Related to Gadoxetate Disodium-Enhanced Liver MRI: Frequency and Risk Evaluation at a German Institution.
Well L; Rausch VH; Adam G; Henes FO; Bannas P
Rofo; 2017 Jul; 189(7):651-660. PubMed ID: 28445909
[No Abstract] [Full Text] [Related]
5. Transient severe motion in the arterial phase during gadoxetate disodium-enhanced MR imaging: evaluation of patients with multiple MR examinations.
Im WH; Song JS; Park EH; Kwak HS
Abdom Radiol (NY); 2017 Oct; 42(10):2393-2401. PubMed ID: 28396919
[TBL] [Abstract][Full Text] [Related]
6. Influence of Gadoxetate Disodium on Oxygen Saturation and Heart Rate during Dynamic Contrast-enhanced MR Imaging.
Hayashi T; Saitoh S; Tsuji Y; Takahashi J; Tagaya N; Hiramoto M; Fukuzawa K; Tano M; Miyati T; Kumada H
Radiology; 2015 Sep; 276(3):756-65. PubMed ID: 25811243
[TBL] [Abstract][Full Text] [Related]
7. Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial.
McClellan TR; Motosugi U; Middleton MS; Allen BC; Jaffe TA; Miller CM; Reeder SB; Sirlin CB; Bashir MR
Radiology; 2017 Feb; 282(2):361-368. PubMed ID: 27509544
[TBL] [Abstract][Full Text] [Related]
8. Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and gadobenate dimeglumine: an intra-individual comparative study in cirrhotic patients.
Furlan A; Close ON; Borhani AA; Wu YH; Heller MT
Clin Radiol; 2017 Jan; 72(1):93.e1-93.e6. PubMed ID: 27633725
[TBL] [Abstract][Full Text] [Related]
9. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality.
Davenport MS; Viglianti BL; Al-Hawary MM; Caoili EM; Kaza RK; Liu PS; Maturen KE; Chenevert TL; Hussain HK
Radiology; 2013 Feb; 266(2):452-61. PubMed ID: 23192781
[TBL] [Abstract][Full Text] [Related]
10. Transient Severe Respiratory Motion Artifacts After Application of Gadoxetate Disodium: What We Currently Know.
Well L; Weinrich JM; Adam G; Bannas P
Rofo; 2018 Jan; 190(1):20-30. PubMed ID: 29156475
[TBL] [Abstract][Full Text] [Related]
11. Transient respiratory motion artifacts in multiple arterial phases on abdominal dynamic magnetic resonance imaging: a comparison using gadoxetate disodium and gadobutrol.
Tanabe M; Higashi M; Iida E; Onoda H; Ihara K; Ariyoshi S; Kameda F; Miyoshi K; Furukawa M; Okada M; Ito K
Jpn J Radiol; 2021 Feb; 39(2):178-185. PubMed ID: 32959222
[TBL] [Abstract][Full Text] [Related]
12. Transient respiratory motion artifact during arterial phase MRI with gadoxetate disodium: risk factor analyses.
Kim SY; Park SH; Wu EH; Wang ZJ; Hope TA; Chang WC; Yeh BM
AJR Am J Roentgenol; 2015 Jun; 204(6):1220-7. PubMed ID: 26001231
[TBL] [Abstract][Full Text] [Related]
13. Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method.
Song JS; Choi EJ; Park EH; Lee JH
Eur Radiol; 2018 Mar; 28(3):1132-1139. PubMed ID: 28986630
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
15. Dose-toxicity relationship of gadoxetate disodium and transient severe respiratory motion artifact.
Davenport MS; Bashir MR; Pietryga JA; Weber JT; Khalatbari S; Hussain HK
AJR Am J Roentgenol; 2014 Oct; 203(4):796-802. PubMed ID: 25055154
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of incidence of acute transient dyspnea and related artifacts after administration of gadoxetate disodium: a prospective observational study.
Grazioli L; Faletti R; Frittoli B; Battisti G; Ambrosini R; Romanini L; Gatti M; Fonio P
Radiol Med; 2018 Dec; 123(12):910-917. PubMed ID: 30084108
[TBL] [Abstract][Full Text] [Related]
17. Respiratory motion in children and young adults undergoing liver magnetic resonance imaging with intravenous gadoxetate disodium contrast material.
Gilligan LA; Trout AT; Anton CG; Schapiro AH; Towbin AJ; Dillman JR
Pediatr Radiol; 2019 Aug; 49(9):1171-1176. PubMed ID: 31203405
[TBL] [Abstract][Full Text] [Related]
18. MRI assessment of biliary ductal obstruction: is there added value of T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR cholangiography?
Reiner CS; Merkle EM; Bashir MR; Walle NL; Nazeer HK; Gupta RT
AJR Am J Roentgenol; 2013 Jul; 201(1):W49-56. PubMed ID: 23789696
[TBL] [Abstract][Full Text] [Related]
19. Reducing artifacts of gadoxetate disodium-enhanced MRI with oxygen inhalation in patients with prior episode of arterial phase motion: intra-individual comparison.
Namimoto T; Shimizu K; Nakagawa M; Kikuchi Y; Kidoh M; Oda S; Nakaura T; Utsunomiya D; Yamashita Y
Clin Imaging; 2018; 52():11-15. PubMed ID: 29494992
[TBL] [Abstract][Full Text] [Related]
20. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
